Sanofi India Earnings

The company had posted a net profit of Rs 72.5 crore in the same quarter last fiscal, Sanofi India said in a BSE filing.

Pharmaceuticals firm Sanofi India on Friday reported 24.96 per cent increase in net profit at Rs 80.6 crore for the first quarter ended March 31.

In a separate filing, Sanofi India said its Board has recommended a final dividend of Rs 25 per equity share of Rs 10 for the year ended December 31, 2015. An interim dividend of Rs 18 per equity share of Rs 10 had been paid in August 2015.

Drug firm Sanofi India on Tuesday reported 16.93 per cent rise in its standalone net profit to Rs 72.5 crore for the third quarter ended September 30, 2015.

Drug firm Sanofi India on Tuesday reported an 11.65 per cent rise in standalone net profit at Rs 64.2 crore for the fiscal second quarter that ended on June 30, 2015.

Drug firm Sanofi India on Wednesday reported a 24.75 per cent increase in net profit at Rs 64.5 crore for the quarter ended March 31, 2015, aided by an exceptional income of Rs 16.1 crore.

Drug firm Sanofi India has reported a 12.30 per cent increase in net profit at Rs 57.5 crore for the second quarter that ended on June 30, 2014.

Drug firm Sanofi India has reported a 16.44 per cent increase in its net profit at Rs 51.7 crore for the first quarter that ended on March 31, 2014.

Sanofi India's net profit for the quarter ended December 31, 2013, witnessed over two-fold increase on account of robust sales in export markets. The company had posted a net profit of Rs 44.8 crore during the same period of the previous fiscal.

The company had posted a net profit of Rs 72.5 crore in the same quarter last fiscal, Sanofi India said in a BSE filing.

Pharmaceuticals firm Sanofi India on Friday reported 24.96 per cent increase in net profit at Rs 80.6 crore for the first quarter ended March 31.

In a separate filing, Sanofi India said its Board has recommended a final dividend of Rs 25 per equity share of Rs 10 for the year ended December 31, 2015. An interim dividend of Rs 18 per equity share of Rs 10 had been paid in August 2015.

Drug firm Sanofi India on Tuesday reported 16.93 per cent rise in its standalone net profit to Rs 72.5 crore for the third quarter ended September 30, 2015.

Drug firm Sanofi India on Tuesday reported an 11.65 per cent rise in standalone net profit at Rs 64.2 crore for the fiscal second quarter that ended on June 30, 2015.

Drug firm Sanofi India on Wednesday reported a 24.75 per cent increase in net profit at Rs 64.5 crore for the quarter ended March 31, 2015, aided by an exceptional income of Rs 16.1 crore.

Drug firm Sanofi India has reported a 12.30 per cent increase in net profit at Rs 57.5 crore for the second quarter that ended on June 30, 2014.

Drug firm Sanofi India has reported a 16.44 per cent increase in its net profit at Rs 51.7 crore for the first quarter that ended on March 31, 2014.

Sanofi India's net profit for the quarter ended December 31, 2013, witnessed over two-fold increase on account of robust sales in export markets. The company had posted a net profit of Rs 44.8 crore during the same period of the previous fiscal.